Forte biosciences inc FBRX.US Value Analysis
US StockHealth Care
(No presentation for FBRX)
FBRX Value Score
3
24
15
Poor Growth
- AI analysis rates FBRX with the lowest value score of 1.
- It is mainly due to unstable operating cash flow, along with potential value may be lower.
- Over the past 3 months, FBRX has maintained an average value rating of 1.2, slightly lower than the rating of 2.5 over the past 3 years, indicating slight decrease in enterprise value.
- Compared to all stocks in the Health Care sector, FBRX has a lower value rating.
FBRX Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
No related data records
Update to 2025/04/05 (Weekly Update)
FBRX Financial Forecast
Unit : USD
Update to 2025/5/4 (Quarterly Update)
FBRX Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | -7.5 | - | -12.3% | 9K | - | -12.3% | -97,866.7% |
Update to 2025/5/8 (Quarterly Update)
FBRX Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
FBRX Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of FBRX from 2017/04 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from April, 2017 to May, 2025. (Total Trades: 0)
| FBRX | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 44% | 53% |
| Avg Return | - | 63.1% | 72.3% |
| Avg Profit | - | 198.4% | 166.4% |
| Avg Loss | - | -44.8% | -34.6% |
| Avg Risk-Reward Ratio | - | 442.5% | 480.4% |
Update to 2025/5/8 (Daily Update)